You are here

  • Home
  • Online First
  • Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission

Article metrics

Article menu

other Versions

Download PDFPDF
Original research
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission

 

Online download statistics by month:

Online download statistics by month: March 2021 to April 2024

AbstractFullPdf
Mar 2021434128
Apr 2021823125
May 20217064
Jun 2021305
Aug 2021532
Sep 2021323
Oct 20217621
Nov 202111301
Dec 20217211
Jan 202211510
Feb 20227400
Mar 202214111
Apr 20227011
May 20229900
Jun 202211821
Jul 20229910
Aug 202223640
Sep 202218320
Oct 20228543
Nov 202211701
Dec 20225122
Jan 20237310
Feb 202310100
Mar 20237311
Apr 20233100
May 20237800
Jun 20232210
Jul 20234910
Aug 20236000
Sep 20236800
Oct 20232301
Nov 20234211
Dec 20237421
Jan 20243310
Feb 20248100
Mar 20243911
Apr 20242700
Total38616544